Fundamentals of randomized clinical trials in wound care: Design and conduct

The care for chronic and acute wounds is a substantial problem around the world. This has led to a plethora of products to accelerate healing. Unfortunately, the quality of studies evaluating the efficacy of such wound care products is frequently low. Randomized clinical trials are universally ackno...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Wound repair and regeneration 2012-07, Vol.20 (4), p.449-455
Hauptverfasser: Eskes, Anne M., Brölmann, Fleur E., Sumpio, Bauer E., Mayer, Dieter, Moore, Zena, Ågren, Magnus S., Hermans, Michel, Cutting, Keith, Legemate, Dink A., Ubbink, Dirk T., Vermeulen, Hester
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The care for chronic and acute wounds is a substantial problem around the world. This has led to a plethora of products to accelerate healing. Unfortunately, the quality of studies evaluating the efficacy of such wound care products is frequently low. Randomized clinical trials are universally acknowledged as the study design of choice for comparing treatment effects, as they eliminate several sources of bias. We propose a framework for the design and conduct of future randomized clinical trials that will offer strong scientific evidence for the effectiveness of wound care interventions. While randomization is a necessary feature of a robust comparative study, it is not sufficient to ensure a study at low risk of bias. Randomized clinical trials should also ensure adequate allocation concealment and blinding of outcome assessors, apply intention‐to‐treat analysis, and use patient‐oriented outcomes. This article proposes strategies for improving the evidence base for wound care decision making.
ISSN:1067-1927
1524-475X
DOI:10.1111/j.1524-475X.2012.00799.x